Oral Microbiome Mediated Inflammation, a Potential Inductor of Vascular Diseases: a Comprehensive Review
Overview
Authors
Affiliations
The dysbiosis of the oral microbiome and vascular translocation of the periodontopathic microorganism to peripheral blood can cause local and systemic extra-oral inflammation. Microorganisms associated with the subgingival biofilm are readily translocated to the peripheral circulation, generating bacteremia and endotoxemia, increasing the inflammation in the vascular endothelium and resulting in endothelial dysfunction. This review aimed to demonstrate how the dysbiosis of the oral microbiome and the translocation of oral pathogen-induced inflammation to peripheral blood may be linked to cardiovascular diseases (CVDs). The dysbiosis of the oral microbiome can regulate blood pressure and activate endothelial dysfunction. Similarly, the passage of periodontal microorganisms into the peripheral circulation and their virulence factors have been associated with a vascular compartment with a great capacity to activate endothelial cells, monocytes, macrophages, and plaquettes and increase interleukin and chemokine secretion, as well as oxidative stress. This inflammatory process is related to atherosclerosis, hypertension, thrombosis, and stroke. Therefore, oral diseases could be involved in CVDs via inflammation. The preclinic and clinical evidence suggests that periodontal disease increases the proinflammatory markers associated with endothelial dysfunction. Likewise, the evidence from clinical studies of periodontal treatment in the long term evidenced the reduction of these markers and improved overall health in patients with CVDs.
Pathophysiological Responses of Oral Keratinocytes After Exposure to Flavored E-Cigarette Liquids.
Shamim A, Herzog H, Shah R, Pecorelli S, Nisbet V, George A Dent J (Basel). 2025; 13(2).
PMID: 39996934 PMC: 11854566. DOI: 10.3390/dj13020060.
Gingipains protect Porphyromonas gingivalis from macrophage-mediated phagocytic clearance.
Widziolek M, Mieszkowska A, Marcinkowska M, Salamaga B, Folkert J, Rakus K PLoS Pathog. 2025; 21(1):e1012821.
PMID: 39836688 PMC: 11801703. DOI: 10.1371/journal.ppat.1012821.
Duque Duque A, Chaparro Padilla A, Almeida M, Marin Jaramillo R, Romanelli H, Lafaurie Villamil G Braz Oral Res. 2024; 38(suppl 1):e120.
PMID: 39607151 PMC: 11665974. DOI: 10.1590/1807-3107bor-2024.vol38.0120.
From Global to Nano: A Geographical Perspective of .
Ryder M, Fine D, Barron A Pathogens. 2024; 13(10).
PMID: 39452709 PMC: 11510556. DOI: 10.3390/pathogens13100837.
Periodontitis impacts on thrombotic diseases: from clinical aspect to future therapeutic approaches.
Ge J, Zhu X, Weng C, Yuan D, Zhao J, Zhao L Int J Oral Sci. 2024; 16(1):58.
PMID: 39402049 PMC: 11473739. DOI: 10.1038/s41368-024-00325-9.